Loading clinical trials...
Loading clinical trials...
A Multicenter Observational Study for Ex-vivo Evaluation of the Likelihood of Response to an Experimental Tolerance Restoration Therapy in Subjects Diagnosed With Multiple Sclerosis (MS)
Conditions
Locations
4
United States
The Johns Hopkins University
Baltimore, Maryland, United States
MedStar Health
Chevy Chase, Maryland, United States
Corinne Goldsmith Dickinson Center for MS
New York, New York, United States
Mellen Center
Cleveland, Ohio, United States
Start Date
March 28, 2023
Primary Completion Date
April 30, 2024
Completion Date
April 30, 2024
Last Updated
June 11, 2024
NCT06276634
NCT05359653
NCT06138132
NCT06390930
NCT03401879
NCT06389968
Lead Sponsor
LAPIX Therapeutics Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions